Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future.
Sikiric. Predrag P; Hahm. Ki-Baik KB; Blagaic. Alenka Boban AB; Tvrdeic. Ante A; Pavlov. Katarina Horvat KH; Petrovic. Andrea A; Kokot. Antonio A; Gojkovic. Slaven S; Krezic. Ivan I; Drmic. Domagoj D; Rucman. Rudolf R; Seiwerth. Sven S
Key Findings
- BPC‑157 protects stomach cells and maintains gastric lining against harmful agents like alcohol and NSAIDs.
- It extends protection to other organs (skin, liver, pancreas, heart, brain) and promotes wound healing.
- The peptide safeguards blood‑vessel endothelium, improves blood flow around blockages, and reduces bleeding and clotting problems.
- It counteracts tumor‑related muscle wasting by lowering pro‑inflammatory cytokines and modulating muscle‑growth signaling pathways.
Practical Outcomes
- For biohackers, BPC‑157 looks promising for gut health, wound repair, vascular support, and preventing muscle loss, but the evidence is still mainly pre‑clinical. If you choose to try it, start with low, animal‑study‑based doses, track any side effects, and treat it as an experimental supplement rather than a proven therapy.
Summary
BPC‑157 is a tiny protein that naturally lives in the stomach lining and seems to protect the gut and many other organs. The review says it can shield the stomach from alcohol, NSAIDs, and other damage, help heal wounds in skin, liver, heart and brain, keep blood vessels healthy, and even fight muscle loss and inflammation seen in cancer cachexia. However, the paper is a broad overview and does not give specific dosing or step‑by‑step protocols.
Abstract
We reviewed again the significance of the stable gastric pentadecapeptide BPC 157 as a likely mediator of Robert's stomach cytoprotection/adaptive cytoprotection and organoprotection and as novel mediator of Selye's stress coping response to reestablish homeostasis. Specific points of BPC 157 therapy and the original concept of Robert's cytoprotection/adaptive cytoprotection/organoprotection are discussed, including the beneficial effects of BPC 157. First, BPC 157 protects stomach cells and maintains gastric integrity against various noxious agents (Robert's killing cell by contact) and is continuously present in the gastric mucosa and gastric juice. Additionally, BPC 157 protects against the adverse effects of alcohol and nonsteroidal anti-inflammatory drugs on the gastric epithelium and other epithelia, that is, skin, liver, pancreas, heart (organoprotection), and brain, thereby suggesting its use in wound healing. Additionally, BPC 157 counteracts gastric endothelial injury that precedes and induces damage to the gastric epithelium and generalizes "gastric endothelial protection" to protection of the endothelium of other vessels (thrombosis, prolonged bleeding, and thrombocytopenia). BPC 157 also has an effect on blood vessels, resulting in vessel recruitment that circumvents vessel occlusion and the development of additional shunting and rapid bypass loops to rapidly reestablish the integrity of blood flow (ischemic/reperfusion colitis, duodenal lesions, cecal perforation, and inferior vena caval occlusion). Lastly, BPC 157 counteracts tumor cachexia, muscle wasting, and increases in pro-inflammatory/procachectic cytokines, such as interleukin-6 and tumor necrosis factor-α, and significantly corrects deranged muscle proliferation and myogenesis through changes in the expression of FoxO3a, p-AKT, p-mTOR, and p-GSK-3β (mitigating cancer cachexia).
Study Information
pubmed
2020
2020-03-15T00:00:00.000Z
10.5009/gnl18490
41
161